Intravenous immunoglobulin for neuromuscular disease: costs, benefits and reimbursement.
Griffin
John W
JW
Hughes
Richard A C
RA
D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics* / Q000627:therapeutic use*; D009468:Neuromuscular Diseases / Q000191:economics* / Q000628:therapy*
D016756:Immunoglobulins, Intravenous